Vanda Pharmaceuticals
VNDA
#7535
Rank
A$0.59 B
Marketcap
A$10.08
Share price
1.54%
Change (1 day)
50.95%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -A$0.19 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.21 Billion. In 2024 the company made an earning of -A$56.4 Million a decrease over its 2023 earnings that were of -A$19.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.19 Billion233.55%
2024 -A$56.4 Million191.43%
2023 -A$19.36 Million-320.45%
2022 A$8.77 M-84.99%
2021 A$58.48 M54.8%
2020 A$37.78 M19.42%
2019 A$31.63 M4.93%
2018 A$30.15 M-228.6%
2017 -A$23.45 Million-8.98%
2016 -A$25.76 Million-53.79%
2015 -A$55.74 Million-30.18%
2014 -A$79.84 Million173.08%
2013 -A$29.24 Million-25.33%
2012 -A$39.15 Million163.61%
2011 -A$14.86 Million-221.15%
2010 A$12.25 M-124.53%
2009 -A$49.98 Million-29.44%
2008 -A$70.83 Million-36.2%
2007 -A$0.12 Billion21.81%
2006 -A$91.15 Million170.55%
2005 -A$33.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.53 B-27,807.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.68 B-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.13 B-8,516.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$35.69 B-21,348.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$31.10 B-18,617.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.93 B-7,803.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-A$3.9 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA